
Caristo Diagnostics Showcases AI-Driven Cardiac Risk Assessment at SCCT
Three of the six finalists for the SCCT 2026 Young Investigator Award are utilizing Caristo Diagnostics' AI technology, marking a significant milestone for the firm. The research, drawn from the expansive ORFAN registry, includes the first-ever application of the FAI-Score on non-contrast cardiac CT scans.





,regionOfInterest=(1885.5,1060.5)&hash=96bb5d0052000c4305d1cb05f6a01e7d758416f92d5daf9a53b5ada2b73c09f5)

















